BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8876845)

  • 1. Western blot banding patterns of HIV rapid progressors in the U.S. Navy Seropositive Cohort: implications for vaccine development. Navy Retroviral Working Group.
    Garland FC; Garland CF; Gorham ED; Brodine SK
    Ann Epidemiol; 1996 Jul; 6(4):341-7. PubMed ID: 8876845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific western blot bands are associated with initial CD4+ lymphocyte counts in human immunodeficiency virus seroconverters. The Navy HIV Working Group.
    Garland FC; Garland CF; Gorham ED; Brodine SK; Weiss PJ
    Ann Epidemiol; 1994 Jan; 4(1):27-31. PubMed ID: 7911377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigen.
    Morand-Joubert L; Bludau H; Lerable J; Petit JC; Lefrère JJ
    J Med Virol; 1995 Sep; 47(1):87-91. PubMed ID: 8551265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working Group.
    Gorham ED; Garland FC; Mayers DL; Goforth RR; Brodine SK; Wiess PJ; McNally MS
    Arch Intern Med; 1993 Apr; 153(7):869-76. PubMed ID: 8096691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.
    Keet IP; Janssen M; Veugelers PJ; Miedema F; Klein MR; Goudsmit J; Coutinho RA; de Wolf F
    J Infect Dis; 1997 Sep; 176(3):665-71. PubMed ID: 9291313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
    Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J;
    AIDS; 2015 Nov; 29(17):2323-33. PubMed ID: 26544704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
    MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
    Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care.
    Schechter MT; Hogg RS; Aylward B; Craib KJ; Le TN; Montaner JS
    J Clin Epidemiol; 1994 Jan; 47(1):59-67. PubMed ID: 7904296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.
    Carotenuto P; Looij D; Keldermans L; de Wolf F; Goudsmit J
    AIDS; 1998 Sep; 12(13):1591-600. PubMed ID: 9764777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.
    Mandalia S; Westrop SJ; Beck EJ; Nelson M; Gazzard BG; Imami N
    PLoS One; 2012; 7(2):e29844. PubMed ID: 22363409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary immunoglobulin A antibodies to gp41 in human immunodeficiency virus-seropositive patients: lack of correlation with disease progression.
    Toro MJ; Escalona L; Chaiyarit P; Warner NA; Gregory RL
    Oral Microbiol Immunol; 2001 Jun; 16(3):188-92. PubMed ID: 11358543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.
    Liovat AS; Rey-Cuillé MA; Lécuroux C; Jacquelin B; Girault I; Petitjean G; Zitoun Y; Venet A; Barré-Sinoussi F; Lebon P; Meyer L; Sinet M; Müller-Trutwin M
    PLoS One; 2012; 7(10):e46143. PubMed ID: 23056251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression markers during asymptomatic phase of HIV-1 infected children with unimpaired CD4+ cell values: evaluation of repeat CD4+ cell evaluation vs. other immunological parameters.
    Chattopadhya D; Baveja UK; Bose M; Kumar A
    J Trop Pediatr; 2002 Dec; 48(6):340-7. PubMed ID: 12521275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.
    Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F
    J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors.
    Audigé A; Taffé P; Rickenbach M; Battegay M; Vernazza P; Nadal D; Speck RF;
    AIDS Res Hum Retroviruses; 2010 Sep; 26(9):997-1005. PubMed ID: 20715931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of antigen-specific antibody response detectable by western blot in relation to diagnostic criteria for human immunodeficiency virus type-1 (HIV-1) infection.
    Chattopadhya D; Aggarwal RK; Kumari S
    Clin Diagn Virol; 1996 Oct; 7(1):35-42. PubMed ID: 9077428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Postseroconversion CD4
    Palm AA; Lemey P; Jansson M; Månsson F; Kvist A; Szojka Z; Biague A; da Silva ZJ; Rowland-Jones SL; Norrgren H; Esbjörnsson J; Medstrand P
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
    Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
    AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
    Klein MR; van Baalen CA; Holwerda AM; Kerkhof Garde SR; Bende RJ; Keet IP; Eeftinck-Schattenkerk JK; Osterhaus AD; Schuitemaker H; Miedema F
    J Exp Med; 1995 Apr; 181(4):1365-72. PubMed ID: 7699324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.